Condition
Pheochromocytoma/Paraganglioma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Pheochromocytoma/Paraganglioma clinical trials that are recruiting, at sites in 23 countries (most in United States (2), United Kingdom (2), China (2)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 23Countries
Newest Pheochromocytoma/Paraganglioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma | Phase 2 | Cambridge, Cambridgeshire | Recruiting | Jul 2, 2026 |
| Real-world belzutifan outcomes and pharmacogenetics in von Hippel-Lindau syndrome | Phase 2 | São Paulo, São Paulo | Recruiting | Sep 11, 2025 |
| Using Ivocizumab to treat various advanced rare tumors | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 12, 2024 |
| Treatment of advanced tumors with belzutifan | Phase 2 | Los Angeles, California and 84 other locations | Recruiting | Jun 11, 2021 |
| Investigating genetic factors in childhood cancer | — | Memphis, Tennessee | Recruiting | Feb 10, 2017 |
All recruiting trials (5)
-
Belzutifan and catecholamine metabolism in pheochromocytoma/paraganglioma
This study tests whether Belzutifan can change how catecholamines are produced and broken down in adults with pheochromocytoma or paraganglioma.
-
Real-world belzutifan outcomes and pharmacogenetics in von Hippel-Lindau syndrome
This study will test belzutifan in people aged 14 and older with VHL syndrome to see how well it controls VHL-associated tumors, what side effects occur, and how genetic factors affect response.
-
Using Ivocizumab to treat various advanced rare tumors
This study is testing if a new treatment called Ivocizumab can help people with different types of advanced rare tumors feel better and live longer.
-
Treatment of advanced tumors with belzutifan
This study is testing a new medication called belzutifan to see if it can help people with advanced tumors related to specific conditions feel better and respond to treatment.
-
Investigating genetic factors in childhood cancer
This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.
Related topics
Quick answers
How many Pheochromocytoma/Paraganglioma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in United States (2 trials), United Kingdom (2 trials), China (2 trials), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.